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Abstract
The serine/threonine phosphatase type 2C (PPM1A) has a broad range of substrates, and its role in regulating stress
response is well established. We have investigated the involvement of PPM1A in the survival and differentiation processes of
PC6-3 cells, a subclone of the PC12 cell line. This cell line can differentiate into neuron like cells upon exposure to nerve
growth factor (NGF). Overexpression of PPM1A in naive PC6-3 cells caused cell cycle arrest at the G2/M phase followed by
apoptosis. Interestingly, PPM1A overexpression did not affect fully differentiated cells. Using PPM1A overexpressing cells
and PPM1A knockdown cells, we show that this phosphatase affects NGF signaling in PC6-3 cells and is engaged in neurite
outgrowth. In addition, the ablation of PPM1A interferes with NGF-induced growth arrest during differentiation of PC6-3
cells.
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Introduction
Ser/Thr phosphatases can be divided into two major families,
the PPP family (containing the PP1, PP2A and PP2B subfamilies)
and the PPM family (that contains the PPM1 subfamily, formerly
PP2C). The two groups are distinguished by several differences:
PPMs consist of monomeric, Mg
2+-dependent phosphatases, while
PPPs are multi-subunit enzymes [1], [2]. The PPM1 family of
phosphatases is insensitive to any known inhibitor. To date, at
least 16 distinct PPM1 genes have been found in the human
genome, which encode for at least 22 isoforms [3]. Members of the
PPM1 family are highly conserved in evolution as evident from the
growing list of orthologs reported in both higher and lower
eukaryotes [4]. The role of PPM1A (formerly PP2Ca) in regulating
stress response pathways is well established. The involvement of
PPM1A in negative regulation of various stress-induced pathways
via the mitogen-activated protein kinase (MAPK) was shown in
budding yeasts, fission yeasts, plants and mammals (reviewed in3).
These phosphatases were also reported to participate in various
other cellular signaling such as cell cycle, DNA checkpoint, growth
related pathways and apoptosis [5,6,7,8,9,10,11,12]. Our research
focuses on PPM1A, the most characterized member of the PPM1
family. We have previously shown that overexpression of PPM1A
in HEK293 cells can lead to cell cycle arrest in the G2/M phase
and to apoptosis [10],[11].
PPM1A mRNA and protein are highly expressed in different
types of cells in the brain. PPM1A pattern of expression is different
from those reported for other phosphatases, for example PP2B
[13],[14]. However, very few neural substrates of PPM1A have
been identified [15].
The PC12 cell line is a model for studying neuronal
differentiation, survival and signaling [16]. Upon NGF treatment,
PC12 cells differentiate into sympathetic neuron-like cells, charac-
terized by neurite outgrowth and expression of many neuronal
specific proteins [17],[18]. This differentiation process is accompa-
nied by rapid proliferation for 2–3 days followed by growth arrest
[17],[19],[20]. NGF belongs to the neurotrophin family of growth
factors. It binds mainly to the TrkA receptor tyrosine kinase and
leads to its activation. Activated TrkA receptor further stimulates
various signaling cascades, including the phosphatidylinositol 3
kinase (PI3K) and the RAS-MAP kinase pathways [17],[21],[22]. It
has been well established that NGF activates the ERK, JNK and
p38 mitogen-activated protein kinases pathways through the
activation of RAS [23],[24]. The main second messenger of the
PI3K pathway is the serine/threonine kinase AKT [22]. Using
inhibitors of PI3K it was demonstrated that AKT activity is
necessary for NGF induced survival of PC12 cells. Additional
downstream second messengers of PI3K were described. These
include p70s6 kinase, certain isoforms of protein kinase C and the
Rho family of small GTPases [21],[22].
In this study we investigated the role of PPM1A in the regulation
of cell cycle, neuronal differentiation and signaling using the PC6-3
cell line. PC6-3 is a subclone of PC12 cells, which was previously
shown to differentiate in response to NGF [19]. These cells stably
express tetracycline (Tet) repressor and PPM1A under control of
CMV promoter/tetracycline operator. We used the Tet system to
induce expression of the wt and mutant forms of PPM1A and
specific smallinterferenceRNA(shRNA)foritsablation. Wehereby
demonstrate that overexpression of PPM1A caused cell cycle arrest
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fully differentiated cells PPM1A overexpression did not affect cell
growth. We found that the neurite outgrowth process was affected
by PPM1A overexpression and its ablation. Furthermore; the
PI3K/AKT, ERK and p38 signaling cascades were downregulated
in PPM1A overexpressing cells and upregulated in its absence.
Materials and Methods
Plasmids
Inducible PPM1A wt or mutant (PPM1A-pcDNA4) expression
vectors were previously constructed in our laboratory [11]. As
previously published [12], the pSuperRetro-PPM1A was construct-
ed by cloning two annealed oligonucleotides encoding PPM1A
specific shRNA into a pSuperRetro vector (kindly provided by R.
Agami [25]). The pSuperRetro-LacZ was a gift from Y. Shiloh.
Cell culture
Trex
TMPC6-3 (PC6-3) cells were kindly provided by S. Strack.
This cell line, used in this study, stably express the Tet repressor
from pcDNA6/TR vector [19]. The cells were grown in RPMI
1640 medium supplemented with 8% horse serum (HS), 8% fetal
calf serum (FCS), 1% glutamine and 1% pen-strep solution,
containing 2 mg/ml blasticidin (Invitrogen). The cell media and
serum were purchased from Biological Industries, Israel.
For differentiation, PC6-3 cells were seeded in tissue culture
plates coated with mouse tail collagen (kindly provided by R.
Stein). Cells were seeded at a relatively low density (1.5610
5 cells/
60 mm plate) in serum-containing medium. One day after
seeding, the medium was replaced with low serum medium
(RPMI supplemented with 1% HS and 1% FCS) containing
50 ng/ml NGF. Exposure to vehicle alone (low serum culture
medium) was used as the control. The medium supplemented with
fresh NGF was replaced every 3 days during the experiments.
Transfections, infections and establishment of stable
transfected cells
PC6-3 cells were transfected with the Lipofectamine
TM reagent
(Invitrogen) according to manufacturer’s instructions. To establish
PC6-3 cells stably expressing PPM1A wt or mutant, the cells were
transfected with PPM1A wt or mutant-pcDNA4 plasmids. Forty
eight hours after transfection cells were seeded for selection into
fresh medium containing 200 mg/ml zeocine (Invitrogen). Several
stable clones were isolated and analyzed for Tet inducible
expression of PPM1A wt and mutant. The suitable clones were
grown in selective medium. Tet was obtained from Invitrogen. In
all the experiments described below, 250 ng/ml Tet were used to
induce PPM1A expression.
In order to establish shRNA stable cell lines, PC6-3 cells were
transduced with viruses containing small interfering RNAs
(shRNA) against PPM1A (pSuperRetro-PPM1A) and LacZ
(pSuperRetro-LacZ). Stable puromycin-resistant cell populations
expressing shRNA of PPM1A or LacZ were grown in medium
containing 15 mg/ml puromycin (Sigma). Knock down of PPM1A
was verified by western blot analysis.
Colony formation assay
Cells (1000 cells per well) were seeded in 24 wells cell culture
clusters. Twenty-four hours later the medium was replaced with
Tet containing medium. The medium was changed every 3–4 days
until colonies were obtained (10–14 days). The colonies were fixed
with 4% formaldehyde in PBS for 20 minutes, washed once with
water and stained with Giemsa stain (Sigma Diagnostics diluted
1:10 and filtered) for 20 minutes.
Protein Analysis
Cells were lysed in 50 mM Tris, 150 mM NaCl, 5 mM EGTA,
pH 7.5, supplemented with Complete
TM protease inhibitors
(Boehringer-Mannheim), 0.75% NP40, 2 mM Na3VO4,5 0m M
NaF and 10 mM NaPPi. Cell lysis and western blot analysis were
carried out as described before [11].
Antibodies
The following antibodies were used in this study: monoclonal anti-
PPM1A antibodies (for production details see [11]), phospho-Ser473-
AKT (#44-621G; Biosource), total-AKT (#SAB4500797; Sigma),
phospho-Thr180/Tyr182-p38 (#M8177; Sigma), total-p38 (#M0800;
Sigma), cleaved-caspase3 (#9661; Cell Signaling Technology),
phospho-ERK1(T202/Y204)/ERK2(T185/Y187) (#F1018; R&D
Systems), total-ERK (#sc-154; Santa Cruz Biotechnology), p53
(CM5) (#VP-P956; Vector Laborites), MDM2 (4B2 & 2A9; a gift
from M. Oren), anti-BrdU (# M 0744; DAKO).
XTT assay
Cells (1610
4 cells/well) were seeded in 96 well cell culture
clusters coated with collagen. Next day, the regular medium was
Figure 1. Characterization of stable cell lines expressing PPM1A under the regulation of a Tet-regulated promoter. PC6-3 cells
expressing wt PPM1A were incubated for (A) 48 hours with increasing concentrations of Tet, or (B) for 0, 4, 8, 24, and 48 hours with 250 ng/ml Tet.
PPM1A expression was detected using western blot analysis and specific anti-PPM1A antibodies. p38 served as a loading control. The results shown in
(A) and (B) are of representative experiments out of three. (C) Extracts from the experiment discussed in (B) were assayed for phosphatase activity.
The graph shows the average activity of 4 samples from each time point 6 standard deviation from one of 3 independent experiments performed.
* P-value,0.002.
doi:10.1371/journal.pone.0032438.g001
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without NGF (50 ng/ml) and with or without Tet for the indicated
time. The cells were then assayed for viability according to
manufacturer directions (Biological Industries, Israel).
Flow Cytometry Analysis and BromoDeoxyUridine (BrdU)
staining
Cells were seeded (1610
6 cells per 60 mm plates) and Tet was
added onthe nextday.Fourhours later100 mMofBrdU was added
for a 6 hours pulse. The cells were harvested at the indicated time
periods after Tet addition and fixed with 70% ethanol. The cells
were incubated for 20 min with PBS/0.5%Triton X-100 (v/v)/
1.5 N HCL at RT, followed by addition of 0.1 M sodium
tetraborate (Na2BaO7.10H2O) for 10 minutes. The cells were
washedandincubatedwith 50 mlofantiBrdUantibodiesfor1 hour
at RT and with 50 ml of anti-mouse IgG FITC antibody for 1 hour
at RT. The cells were resuspended in PBS containing 0.1% NaN3.
For nuclear staining, propidium iodide (50 mg/ml) was added, and
the cells were analyzed using fluorescence-activated cell sorter
(FACS Caliber, Becton Dickinson).
Phosphatase activity assays
The activity of PPM1A was measured using the radioactive assay
[26]. Briefly, the radioactive phosphatase assay reactions were carried
out in a total volume of 30 ml. 15 mg of total extracts were mixed with
5 mM okadaic acid (for the inhibition of other protein phosphatases),
5m MM g C l 2,a n d1 0 ml
32P-labeled casein (60,000 cpm). After
25 min of incubation at 30uC the reaction was terminated by cold
20% (w/v) TCA and centrifugation. The free
32Pi in the supernatant
was determined by scintillation counter. Control reactions were
carried out in reactions in which protein or magnesium was omitted.
Statistics
The unpaired 2-tailed Student’s t-test was employed in order to
compare means for statistical difference. The data in this study is
represented as mean 6 standard deviation (S.D). Values of
P,0.05 were considered significant.
Results
Generation and characterization of PC6-3 cell lines stably
expressing different levels of PPM1A
We have previously shown that PPM1A overexpression inhibits
the proliferation of HEK293 cells and induces cell death, thus
preventing the establishment of stable clones constitutively
overexpressing PPM1A [10], [11]. Similarly, we failed to obtain
stable PC6-3 cells overexpressing this phosphatase. Therefore, we
constructed Tet inducible cell lines expressing wt and mutant
PPM1A. This mutant has lost its catalytic activity due to the
replacement of Aspartic acid 239 with Alanine [11]. As shown in
Figures 1A and 1B, PPM1A induction depended on Tet
concentration and the time after its addition. PPM1A phosphatase
activity was significantly enhanced upon its induction (Fig. 1C).
The reduction in PPM1A activity 48 hours after Tet induction can
be attributed to the death of cells expressing high PPM1A levels. It
should be noted that cells overexpressing PPM1A mutant
displayed basal phosphatase activity despite the very high level
of mutant protein (data not shown).
PPM1A overexpression inhibits cell proliferation and
colony formation
The effect of PPM1A overexpression on the ability of PC6-3
cells to form colonies was examined. As shown in Figure 2A,
PPM1A induction caused a dramatic decrease in colony formation
and even at concentration as low as 3 ng/ml Tet there were no
viable colonies. Overexpression of PPM1A mutant did not
interfere with the ability of the cells to form colonies, demonstrat-
Figure 2. Overexpression of PPM1A wt but not mutant
suppresses colony formation and proliferation. (A) PC6-3 PPM1A
wt or mutant cells were seeded in different Tet concentrations as
indicated and grown for 14 days, fixed and stained with Giemsa dye.
Cell extracts prepared 48 hours after Tet addition were assayed for
PPM1A expression by western blot using anti-PPM1A antibodies. The
results shown are of a representative experiment out of three. (B) Two
clones of PC6-3 PPM1A wt cells (clone 2 and 4) were incubated with or
without Tet for 0, 24, 48 and 72 hours. The cells were then assayed for
viability using the XTT assay. The average of 6 different wells 6
standard deviation from a representative experiment out of three was
plotted. (C) One clone of PC6-3 cells overexpressing PPM1A mutant was
treated as in (B). cl- clone.
doi:10.1371/journal.pone.0032438.g002
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cell survival. Analysis of cell growth using proliferation assay
revealed that it was completely inhibited following PPM1A
induction (Fig. 2B). However, cells overexpressing mutant PPM1A
showed kinetics of cell growth that were similar to the uninduced
cells (Fig. 2C).
PPM1A overexpression induces cell cycle arrest and
apoptosis in PC6-3 cell line
We conclude, according to Figure 2, that overexpression of the
wt form of PPM1A is toxic to PC6-3 cells. The cell proliferation
assay revealed that the total number of cells expressing high levels
of PPM1A did not increase (Fig. 2B). However, it was not clear
whether those cells were able to proliferate but then died, or
whether the cells could not continue with their cell cycle and thus
were arrested and then died. To clear this issue we performed
BrdU pulse-chase together with FACS analysis of induced and
uninduced PC6-3 cells. As shown in Figure 3A, 12 hours after Tet
induction, the induced and uninduced cells exhibited similar cell
cycle distribution. Differences between their cell cycle patterns are
evident as early as twenty two hours after Tet addition. There was
a significant increase in the fraction of PPM1A overexpressing cells
Figure 3. PPM1A overexpression induces cell cycle arrest. FACS analysis (A), and BrdU labeling (B) of PC6-3 cells overexpressing PPM1A wt.
Cells were treated as described in the ‘‘Materials and Methods’’ and analyzed for DNA content by propidium iodide (PI) staining (A) and for BrdU
labeling by anti-BrdU antibodies as represented by the dot plot of DNA content (PI) against BrdU incorporation (B). (C) FACS analysis of PC6-3 cells
overexpressing PPM1A mutant. Cells were incubated with or without Tet, and then analyzed for DNA content by propidium iodide (PI) staining. The
numbers represented in the tables indicate % of total cells in (A) and (C), and % of total BrdU labeled cells in (B). The experiments in (A), (B) and (C)
were performed at least three times.
doi:10.1371/journal.pone.0032438.g003
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G0/G1 phase. This phenomenon was more pronounced 48 and
60 hours after Tet addition. Thus, according to the FACS analysis
(Fig. 3A), PPM1A overexpression leads to cell cycle arrest at the
G2/M phase. The fate of the BrdU pulsed cells verified the G2/M
cell cycle arrest. As shown in Figure 3B, 22 hours after Tet
induction the BrdU labeled cells expressing basal PPM1A levels
transversed from the G2/M to the G0/G1 phase while, the
majority of the BrdU labeled PPM1A overexpressing cells were
arrested at the G2/M phase (53%) and only a very small fraction
(3.5%), of the overexpressing cell moved to G0/G1. Interestingly,
48 hours after Tet induction the fraction of G0/G1 BrdU labeled
cells overexpressing PPM1A increased, suggesting that a portion of
the arrested cells completed the cell cycle and progressed from
G2/M to the G0/G1 phase. Still, the percentage of G0/G1 cells
expressing basal PPM1A levels was higher than that of the PPM1A
overexpressing cells (Fig. 3B, G0/G1 at 48 hours, 53% uninduced
versus 28% Tet induced cells). It should be noted that at later
stages a substantial fraction of the PPM1A overexpressing cells
underwent apoptosis (Fig. 3A 60 hours) and died (Fig. 2). We next
examined whether PPM1A phosphatase activity is important to
the cell cycle arrest phenomenon. As shown in Figure 3C
overexpression of the mutant form of PPM1A for 24 and 48 hours
had no effect on the cell cycle distribution. Altogether, we
conclude that the inhibition of the proliferation of PPM1A
overexpressing cells which was shown in Figure 2B is mainly due
to cell cycle arrest at the G2/M phase, and cells unable to proceed
with their cell cycle undergo apoptosis, as was previously shown in
HEK293 cells [11]. It is not clear whether those cells that
proceeded to the G0/G1 underwent apoptosis or continued to the
G2/M phase and then apoptosed. However, eventually, all
PPM1A overexpressing cells died (Fig. 2A and 2B).
Several studies have demonstrated the requirement for AKT
activity in the G2/M phase transition [27], [28]. Indeed, forty eight
hours after PPM1A induction there was a decrease in the level of
AKT phosphorylation on serine 473 which is required for the
activity of AKT as a survival factor (Fig. 4A). Overexpression of the
mutant form did not affect AKT phosphorylation levels (Fig. 4A).
Cleaved caspase 3 serves as an apoptotic marker [29] and indeed its
elevatedlevelsinPPM1Aoverexpressingcellsindicatetheenhanced
apoptosis (Fig. 4B). Altogether, our cell cycle and biochemical data
demonstrate that in replicating PC6-3 cells PPM1A overexpression
arrests cell cycle progression and induces apoptosis.
In HEK293 the growth arrest and apoptosis induced by PPM1A
overexpression were partially mediated by its effect on p53 protein
[11]. This was shown by p53 elevated protein levels upon PPM1A
induction and increase in its activity as a transcription factor.
However, in PC6-3 cells the elevated PPM1A levels did not increase
the level of p53 or its transcriptional target Mdm2 (Fig. 4C).
PPM1A overexpression inhibits PC6-3 cell proliferation
during differentiation, but does not induce apoptosis of
fully differentiated cells
Upon NGF addition, PC6-3 cells differentiate into neuronal like
cells. During this process the cells proliferate rapidly for
approximately 3 days, and then, concomitantly with the
appearance of neuronal-like extensions, the cells arrest at the
G0/G1 phase. To study the role of PPM1A in the differentiation
process, cells expressing inducible PPM1A were incubated with or
without NGF in the presence or absence of Tet. Cells expressing
basal PPM1A levels underwent rapid replication for 72 hours
followed by proliferation arrest and differentiation into neuronal
like cells (Fig. 5A and Fig. 6). PPM1A overexpression affected the
cells during their proliferation phase and led to the cessation of cell
division (Fig. 5A). Indeed, cell cycle analysis of the NGF-treated
PPM1A overexpressing cells revealed that first, the PPM1A
overexpressing cells accumulated in the G2/M phase and later on,
72 hours after Tet addition, a fraction of the cells underwent
apoptosis (Fig. 5B). Interestingly, afterwards, the fully differenti-
ated cells treated 6 days with NGF and Tet were not further
affected by PPM1A overexpression (Fig. 5A, left), even though it
was still highly expressed (Fig. 5C) and exhibited higher
phosphatase activity than that of untreated cells or uninduced
NGF-treated cells (data not shown). We have also examined the
effect of PPM1A induction on differentiating cells. To this end, the
cells were pretreated with NGF and on the third or fifth days of the
NGF treatment PPM1A was induced by Tet addition. Our
Figure 4. PPM1A overexpression affects cell cycle and survival markers. (A) PC6-3 cells overexpressing wt or mutant PPM1A were incubated
with or without Tet for the indicated times. The cells were then harvested and lysed. Cell extracts were analyzed by western blot for levels of
phosphorylated AKT, total AKT and PPM1A. Note that PPM1A mutant migrates faster than the wt on the gel ([10]) and that even in the absence of Tet
there was a slight expression due to leakiness of PPM1A mutant. PPM1A wt cells were analyzed in the same manner for levels of (B) cleaved caspase 3
and p38. (C) PC6-3 cells overexpressing PPM1A were incubated with or without Tet for 24 hours. The cells were then harvested and lysed and cell
extracts were analyzed for levels of p53, Mdm2, PPM1A and p38 by western blot. The numbers represent the ratio of p53/p38 (0.1, 0.07) and Mdm2/
p38 levels (0.5, 0.5). The blots presented in (A)( B) and (C) are from representative experiments out of three performed.
doi:10.1371/journal.pone.0032438.g004
PPM1A in PC12 Cells Differentiation and Survival
PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e32438findings demonstrated that PPM1A overexpression had no effect
on the viability of the cells (data not shown).
PPM1A overexpression delays neurite extension during
the differentiation process
Next we asked whether PPM1A affects neurite extension and
cellular morphology during the differentiation process. To this
end, cells were seeded on collagen coated plates, and NGF was
added 24 hours later with or without Tet. As seen in Figure 6A, 48
and 72 hours following NGF addition PPM1A overexpressing cells
exhibited shorter extensions than uninduced cells expressing basal
PPM1A levels. However, 7 days after NGF addition both cell types
displayed similar extension length (data not shown).
The interplay between the toxic effect of PPM1A overexpression
and the protective effect of NGF should be noted. On one hand there is
a dramatic reduction in the number of undifferentiated PPM1A
overexpressing cells (Fig. 6A 2NGF +Tet) in comparison to cells
exhibiting basal PPM1A levels (Fig. 6A 2NGF 2Tet). On the other
hand, NGF treatment reduced the toxic effect of PPM1A overexpres-
sion (Fig. 6A +NGF +Tet 48 and 72 hrs). Still, the number of
differentiated cells was lower than in the NGF treated cells expressing
basal PPM1A levels (Fig. 6A +NGF 2Tet 48 and 72 hours).
PPM1A knock down cells continue to proliferate during
PC6-3 differentiation
To investigate the role of endogenous PPM1A in the
differentiation process we established PPM1A knockdown cells
with markedly reduced endogenous PPM1A levels (sia cells), and
siLacZ cells that served as control (Fig. 7A). Note that though the
expression of the endogenous PPM1A was marginal in the sia
Figure 5. PPM1A overexpression and PC6-3 cells differentiation. (A) Cell proliferation assay. PC6-3 PPM1A wt cells were incubated with or
without NGF and with or without Tet. The cells were then assayed for viability at the indicated times using XTT assay. The average of 6 different wells
6 S.D. from a representative experiment was plotted. (B) FACS analysis of PC6-3 cells preincubated with Tet for 24 hours followed by addition of NGF
for the indicated times. The table represents % of total counted cells of one experiments out of three performed. (C) Western blot analysis of extracts
from cells treated for 144 hours with NGF with or without Tet, and assayed for PPM1A expression level with anti-PPM1A antibodies.
doi:10.1371/journal.pone.0032438.g005
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knockdown cells since this assay detects the phosphatase activity of
all PPM1 paralogs and is not specific to PPM1A protein. We
examined the proliferation pattern of PPM1A knockdown cells
and found that in the absence of NGF the cells exhibited a
proliferation pattern similar to that of normal cells (Fig. 7B).
However upon NGF addition there were differences between the
two cell types. Seventy two hours after NGF addition the wt cells
underwent growth arrest while the sia cells continued to proliferate
(Fig. 7C). Furthermore, in the PPM1A ablated cells neurites
appearance was accelerated (Fig. 6B). Interestingly, seven days
after NGF addition both cell types displayed similar morphology.
PPM1A is involved in NGF signaling pathways during
differentiation
It is well established that AKT, ERK and p38 activation is part
of the differentiation process of PC12 cells. We examined the
phosphorylation of AKT and ERK in NGF treated cells
overexpressing PPM1A and in knockdown cells. PPM1A overex-
pression led to decreased levels of phosphorylated AKT and ERK,
while the opposite picture emerged upon the analysis of PPM1A
ablated cells (Fig. 8A and 8B).
p38 is an established substrate of PPM1A, and the interaction
between these two proteins was previously demonstrated [5]. The
role of PPM1A in the p38 pathway during NGF exposure was
examined. In knockdown cells, the levels of phospho-p38 were
dramatically higher and persisted for a longer period in
comparison to the wt cells (Fig. 9). Accordingly, PPM1A
overexpression resulted in reduced phospho-p38 levels in NGF
treated cells (data not shown).
Altogether, these findings demonstrate that PPM1A is involved
in the AKT, ERK and p38 signaling, and its activity as
phosphatase controls the phosphorylation state of these important
proteins which participate in the NGF signaling pathways.
Figure 6. PPM1A expression affects neurite outgrowth. (A) PC6-3 PPM1A wt cells were seeded on collagen coated plates and incubated with
or without NGF and Tet. (B) PC6-3 siLacZ and sia cells were seeded in the same manner and treated with or without NGF. Phase contrast images were
taken at the indicated time periods. The histogram represents quantification of neurite formation from one out of three independent experiments.
Cells with processes twice longer than cell body were counted as positive. At least 100 cells were counted from 5 different areas of each plate and the
average numbers are represented with standard deviation. P-Values: * P-Values,0.01; ** P-Values,0.0005; *** P-Values,0.03; **** P-Values,0.03;
***** P-Values,0.05.
doi:10.1371/journal.pone.0032438.g006
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PC12 cells are used as a model system for the study of neuronal
differentiation, survival and signaling. In this report we propose a
new role for PPM1A in these pathways using PC6-3 cells, a
subclone of PC12 cell line.
PPM1A, cell cycle arrest and apoptosis of PC12 cells
Overexpression of different members of the PPM1 family in
various cell lines was shown to cause cell cycle arrest and apoptosis
[9],[11],[30],[31]. In this study we have examined the effect of
PPM1A on differentiation, viability and survival of PC6-3 cells.
We have shown that PPM1A overexpression leads to immediate
cell cycle arrest at the G2/M phase. This arrest was evident by the
increased fraction of cells in G2/M phase detected by direct cell
cycle analysis and the BrdU pulse chase data. Later on a fraction
of the cells managed to exit G2/M and began a new cell cycle. It is
not clear whether the cells were arrested at the G0/G1 and then
underwent apoptosis, or continued to the G2/M and then
apoptose. The cell cycle arrest corresponds to the cessation of
proliferation that was observed in PPM1A overexpression cells.
Eventually, the halted cells undergo apoptosis. We suggest that the
primary effect of PPM1A is the cell cycle arrest; while the
apoptotic response, shown by the cell cycle analysis and enhanced
caspase 3 cleavage, is due to a secondary effect resulting from the
inability of the arrested cells to resume advance in the cell cycle. In
long term, PPM1A induction leads to reduction in cell number
and colonies formation. We conclude that these effects are
mediated by PPM1A activity as phosphatase, since the mutant
form of the protein, which lacks phosphatase activity, failed to
affect the cell cycle distribution and cell viability.
The low level of phosphorylated AKT upon PPM1A induction
also supported the G2/M phase arrest caused by PPM1A
overexpression, as the involvement of AKT in the G2/M
transition and survival pathways was previously documented
[27],[28]. In addition, Lee et al. demonstrated that in PC12
activated-AKT was necessary to the cells proliferation and cell
cycle progression [32]. It is known that upon its phosphorylation
and activation by the PI3K, AKT activates various anti apoptotic
second messengers and deactivates pro-apoptotic second messen-
gers, such as BAD and the forkhead transcription factors family
[33],[34]. Furthermore, AKT inactivation was demonstrated
during cell death and its down-regulation enhanced basal cell
death [35]. We propose that the effect of PPM1A on the cell cycle
and cell death might be partly attributed to its effect on AKT
dephosphorylation and the activation of forkhead and BAD.
Inhibition of the PI3K/AKT survival pathway also occurs in
PC12 cells, following various stress responses such as oxidative and
ER stress, and serum deprivation. Some of these modes of stress
can lead to neurodegenerative diseases, which are involved in
neuronal death. By affecting the PI3K/AKT pathway PPM1A
might be engaged in regulating these cellular responses and thus
may play a role in neurodegenerative diseases.
PPM1A, PC12 cells differentiation and signaling
The involvement of tyrosine phosphatases in the differentiation
process into neuronal like cells is highly investigated. However, the
role of serine/threonine phosphatases, especially the PPM1 family,
in this process is less studied. The high expression of PPM1A in the
brain, the role of PPM1A and PPM1B in neuroprotection and
neurodegeneration [36],[37], the involvement of PPM1 family
members in other differentiation processes [38],[39], coupled with
our and previous findings on the effect of PPM1A in cell cycle
progression and the regulation of the PI3K/AKT pathway [39],
prompted us to examine whether PPM1A is engaged in the
differentiation of PC12 cells. To this end we used two
complementary approaches and studied PPM1A overexpression
and its ablation in the NGF treated cells. While its overexpression
was toxic to proliferating cells but did not affect the fully
differentiated cells, PPM1A knockdown resulted in delayed growth
arrest and extended proliferation phase upon exposure to NGF. In
Figure 7. Proliferation assay of PPM1A knock-down cells. (A)
PC6-3 cells were transduced with pSuperRetro-PPM1A or pSuperRetro-
LacZ. Forty eight hours later cells were selected by the addition of
puromycin. The protein levels of PPM1A were analyzed by western blot.
The graph represents the quantification of PPM1A levels. (B) and (C)
Proliferation assay of PPM1A knock-down cells compared to normal
cells in the absence (B) or presence (C) of NGF. The average of 6
different wells 6 standard deviation from a representative experiment
out of 3 independent experiments that were performed was plotted.
* P-value of 120 hours ,0.002.
doi:10.1371/journal.pone.0032438.g007
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e32438Figure 8. PPM1A over and underexpression and cell signaling during PC6-3 cells differentiation. (A) PPM1A wt cells were incubated
with or without Tet for 24 hours and then NGF was added for the indicated times. (B) PC6-3 PPM1A knock-down cells and control cells were
incubated with NGF for the indicated times. The cells were harvested and lysed. Cell extracts were analyzed by western blot using the indicated
antibodies. Please note that the AKT and PPM1A panels in (B) are from different gels of the same experiments. The graphs represent quantification of
the blots shown in (A) and (B). The results shown are from representative experiments out of 3 independent that were performed.
doi:10.1371/journal.pone.0032438.g008
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arrest and still facilitates the transit of a fraction of the cells to G0/
G1 (Fig. 3), we suggest that upon NGF treatment of Tet induced
cells there is a competition during the proliferating phase of the
NGF treatment between the signals induced by PPM1A
overexpression and NGF on the cells fate. Cells arrested in the
G2/M due to PPM1A overexpression will probably undergo
apoptosis; however, cells that escape and proceed to the G0/G1
might be protected from the PPM1A toxic effect and will
differentiate. This competition will last as long as the cells are in
the proliferating stage. Then, as the cells stop proliferating and
start to differentiate they can be protected against PPM1A toxicity
and they will probably be found in a cell cycle phase protected
from PPM1A toxic effect such as G0 phase. On the other hand,
basal PPM1A levels are necessary for the normal proliferating
pattern of the differentiating cells, since its ablation hampered the
proliferating halt of the differentiating cells (Fig. 7).
We have demonstrated here that in NGF treated cells the levels
of PPM1A determined the phosphorylation state of AKT, ERK
and p38, proteins that participate in the differentiation process.
While PPM1A overexpression led to reduced phosphorylation, its
ablation resulted in elevation of their phosphorylation. The
signaling pathway(s) through which PPM1A affects the phosphor-
ylation of these proteins are still unknown. One possibility is that
this phosphatase is directly involved in the dephosphorylation of
those proteins. This hypothesis is in accordance with previous
studies in which p38 was shown to be dephosphorylated and
regulated by PPM1A [5]. However, one should consider the
possibility that PPM1A might regulate an upstream protein(s)
which control the signaling pathways of those three proteins. As
mentioned in the introduction, AKT, ERK and p38 are all
signaling cascades controlled by the activity of the receptor
tyrosine kinase TrkA. TrkA is a member of the Trk gene family
which is composed of three related receptors, TrkA, TrkB and
TrkC. TrkA binds specifically to its ligand NGF, and this binding
induces receptor dimerization, auto phosphorylation on specific
tyrosine residues within its intracellular domain and the receptor
activation [40],[41]. Since PPM1A altered these TrkA signaling
pathways, it is possible that it is engaged directly or indirectly in
TrkA activation and thus affects its downstream signaling
cascades. In earlier studies using COS7 and HEK293 cells lacking
Trk receptor, PPM1A did not affect ERK or AKT phosphory-
lation ([42], and P. Ofek unpublished results). These findings
support the hypothesis that PPM1A acts through TrkA.
There is evidence supporting the hypothesis that altered AKT
phosphorylation under NGF exposure conditions results in
inability of PC12 cells to generate proper neuronal extensions
and differentiate normally into neuronal like cells [43]. Overex-
pression of the tumor suppressor PTEN inhibited the development
of neuronal phenotype in PC12 cells [44], while depletion of
PTEN did not prevent neuronal differentiation [45]. In addition,
overexpression of the PP2A regulatory subunit Bc promoted
neuronal differentiation of PC6-3 cells without NGF addition [19].
Similarly, we observed that neuronal extension was also affected
by PPM1A levels. PPM1A ablation led to earlier neuronal
outgrowth while its overexpression delayed their appearance.
NGF treatment of PC12 results in short term and long term
effects on the cells: in the short term NGF stimulates different
signaling cascades immediately upon its addition and in the long
term it leads to growth arrest, morphology changes and
differentiation. Our findings demonstrate that PPM1A participates
in both the immediate and long term NGF effects. It is possible
that the involvement of PPM1A in the differentiation process (its
effect on the neuronal extensions and cell proliferation) is a
Figure 9. Phosphorylation of p38 during NGF treatment is increased in PPM1A underexpressed PC6-3 cells. PC6-3 PPM1A knock-down
cells and control cells were incubated with NGF for the indicated times. The cells were harvested and lysed. Cell extracts were analyzed by western
blot using the indicated antibodies. The graph represents quantification of the phospho-p38 levels. The results shown are from representative
experiments out of 3 independent that were performed.
doi:10.1371/journal.pone.0032438.g009
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cellular signaling.
On the whole, our results indicate that PPM1A has an
important role in the survival and differentiation of PC12 cells
into neuron-like cells. In concert with earlier studies on the
involvement of PPM1A and PPM1B in neurodegeneration and
neuroprotection [36,37,46] PPM1A is probably required during
embryonic development of the central neuronal system (CNS) and
may participate in neuronal death in neurodegenerative diseases.
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